z-logo
open-access-imgOpen Access
Association of Henoch–Schönlein purpura and Graves' disease
Author(s) -
Jae Il Shin,
Jee Min Park,
Ji Hong Kim,
Jae Seung Lee,
Duk Hee Kim,
Ho-Seong Kim,
Pyung Kil Kim
Publication year - 2006
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfl287
Subject(s) - medicine , henoch schonlein purpura , purpura (gastropod) , dermatology , systemic disease , disease , vasculitis , ecology , biology
Sir, We read with interest the article ‘Henoch–Schönlein purpura associated with propylthiouracil overdose’ by Lee et al. [1]. They reported the first case of a patient with Graves’ disease who developed Henoch–Schönlein purpura (HSP) after a propylthiouracil overdose. We wondered whether HSP would have occurred if she had maintained the prescribed dosage. Although a causal relationship between HSP and Graves’ disease or propylthiouracil use is unclear, we recently reported the case of a patient who developed Graves’ disease during ciclosporin treatment for severe HSP nephritis [2], and speculated that these two diseases might be related. In the past 10 years, we have experienced two additional cases of HSP associated with Graves’ disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom